Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct

PC Albuquerque, FL Fonseca, FF Dutra… - Future …, 2014 - Future Medicine
Aims: Glucuronoxylomannan (GXM) is the major polysaccharide component of
Cryptococcus neoformans. We evaluated in this study whether GXM fractions of different …

Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport

ML Rodrigues, L Nimrichter, DL Oliveira, S Frases… - Eukaryotic …, 2007 - Am Soc Microbiol
The mechanisms by which macromolecules are transported through the cell wall of fungi are
not known. A central question in the biology of Cryptococcus neoformans, the causative …

Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival

O Zaragoza, CJ Chrisman, MV Castelli… - Cellular …, 2008 - Wiley Online Library
Cryptococcus neoformans is a facultative intracellular pathogen. The most distinctive feature
of C. neoformans is a polysaccharide capsule that enlarges depending on environmental …

The Presence of Capsule in Cryptococcus neoformans Influences the Gene Expression Profile in Dendritic Cells during Interaction with the Fungus

P Lupo, YC Chang, BL Kelsall, JM Farber… - Infection and …, 2008 - Am Soc Microbiol
The aim of this investigation was to study the effect of polysaccharide capsule on the gene
expression in dendritic cells (DC) during their interaction with Cryptococcus neoformans. To …

More complicated than it seems: The diversity of cryptococcal glucuronoxylomannan

BAG Sena, LJ Jozefowicz, ML Rodrigues - PLoS pathogens, 2023 - journals.plos.org
Polysaccharides are complex carbohydrates composed of more than a dozen
monosaccharide units connected by glycosidic linkages [1]. Unlike proteins and nucleic …

Pathogenesis of Cryptococcus neoformans is Associated with Quantitative Differences in Multiple Virulence Factors

R Blackstock, KL Buchanan, R Cherniak, TG Mitchell… - Mycopathologia, 1999 - Springer
Two isolates of Cryptococcus neoformans were previously described as being highly
divergent in their level of capsule synthesis in vivo and in their virulence for mice. The highly …

Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and …

O Zaragoza, A Casadevall - Cellular microbiology, 2006 - Wiley Online Library
The capsule of the human pathogenic fungus Cryptococcus neoformans presents the
immune system with a formidable problem for phagocytosis. Capsule‐mediated activation of …

Cell wall α‐1,3‐glucan is required to anchor the Cryptococcus neoformans capsule

AJ Reese, TL Doering - Molecular microbiology, 2003 - Wiley Online Library
Cryptococcus neoformans is an opportunistic pathogen responsible for serious disease in
humans. Critical for virulence of this fungus is an elaborate polysaccharide capsule, which …

The Overlooked Glycan Components of the Cryptococcus Capsule

FL Fonseca, FCG Reis, BAG Sena… - Fungal Physiology and …, 2019 - Springer
Pathogenic species of Cryptococcus kill approximately 200,000 people each year. The most
important virulence mechanism of C. neoformans and C. gattii, the causative agents of …

Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan

LE Yauch, JS Lam, SM Levitz - PLoS pathogens, 2006 - journals.plos.org
The major virulence factor of the pathogenic fungi Cryptococcus neoformans and C. gattii is
the capsule. Glucuronoxylomannan (GXM), the major component of the capsule, is a high …